OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A systematic review of studies investigating the acute effects of N-methyl-D -aspartate receptor antagonists on behavioural despair in normal animals suggests poor predictive validity
Martin Viktorov, Matthew P Wilkinson, Victoria C. E. Elston, et al.
Brain and Neuroscience Advances (2022) Vol. 6
Open Access | Times Cited: 14
Martin Viktorov, Matthew P Wilkinson, Victoria C. E. Elston, et al.
Brain and Neuroscience Advances (2022) Vol. 6
Open Access | Times Cited: 14
Showing 14 citing articles:
Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak‐Bargieła, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6713-6713
Open Access | Times Cited: 63
Adam Wojtas, Agnieszka Bysiek, Agnieszka Wawrzczak‐Bargieła, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6713-6713
Open Access | Times Cited: 63
Rapid antidepressant-like effect of non-hallucinogenic psychedelic analog lisuride, but not hallucinogenic psychedelic DOI, in lipopolysaccharide-treated mice
Youge Qu, Lijia Chang, Li Ma, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173500-173500
Closed Access | Times Cited: 32
Youge Qu, Lijia Chang, Li Ma, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 222, pp. 173500-173500
Closed Access | Times Cited: 32
Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Anastasiya Zaytseva, Evelina Bouckova, McKennon J Wiles, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 18
Anastasiya Zaytseva, Evelina Bouckova, McKennon J Wiles, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 18
An integrative view on the cell-type-specific mechanisms of ketamine's antidepressant actions
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Vern Lewis, Gareth M. Rurak, Natalina Salmaso, et al.
Trends in Neurosciences (2024) Vol. 47, Iss. 3, pp. 195-208
Open Access | Times Cited: 7
Delivering a new generation of translational animal models for depression research
Emma Robinson
Behavioural Pharmacology (2025)
Closed Access
Emma Robinson
Behavioural Pharmacology (2025)
Closed Access
Cognitive and affective models of psychedelics in rodents
David J. Anderson, Emma Robinson
International review of neurobiology (2025)
Closed Access
David J. Anderson, Emma Robinson
International review of neurobiology (2025)
Closed Access
The antidepressant potential of (2R,6R)-hydroxynorketamine: A detailed review of pre-clinical findings
Isis Koutrouli, Kristýna Štefková, Rachel R. Horsley
European Journal of Pharmacology (2025), pp. 177604-177604
Closed Access
Isis Koutrouli, Kristýna Štefková, Rachel R. Horsley
European Journal of Pharmacology (2025), pp. 177604-177604
Closed Access
The need for guidance in antidepressant drug development: Revisiting the role of the forced swim test and tail suspension test
Emily R. Trunnell, John F. Baines, Stephen Farghali, et al.
Regulatory Toxicology and Pharmacology (2024) Vol. 151, pp. 105666-105666
Open Access | Times Cited: 4
Emily R. Trunnell, John F. Baines, Stephen Farghali, et al.
Regulatory Toxicology and Pharmacology (2024) Vol. 151, pp. 105666-105666
Open Access | Times Cited: 4
Role of mTOR1 signaling in the antidepressant effects of ketamine and the potential of mTORC1 activators as novel antidepressants
T. KATO
Neuropharmacology (2022) Vol. 223, pp. 109325-109325
Closed Access | Times Cited: 9
T. KATO
Neuropharmacology (2022) Vol. 223, pp. 109325-109325
Closed Access | Times Cited: 9
Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant‐like effects of ketamine
Yongchang Yin, Jiao‐Zhao Yan, Qianqian Wei, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 23, pp. 4874-4889
Closed Access | Times Cited: 1
Yongchang Yin, Jiao‐Zhao Yan, Qianqian Wei, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 23, pp. 4874-4889
Closed Access | Times Cited: 1
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Laith Alexander, David J. Anderson, Luke Baxter, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Laith Alexander, David J. Anderson, Luke Baxter, et al.
British Journal of Pharmacology (2024)
Open Access | Times Cited: 1
Comments to behavioral tests for antidepressant-like actions of (2R,6R)–hydroxynorketamine by Bonaventura et al.
Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2022) Vol. 29, Iss. 1, pp. 3-4
Closed Access | Times Cited: 6
Lijia Chang, Kenji Hashimoto
Molecular Psychiatry (2022) Vol. 29, Iss. 1, pp. 3-4
Closed Access | Times Cited: 6
Assessment of commonly used tests in experimental depression studies according to behavioral patterns of rodents
Zafer Şahin
Medical Review (2023) Vol. 3, Iss. 6, pp. 526-531
Open Access | Times Cited: 2
Zafer Şahin
Medical Review (2023) Vol. 3, Iss. 6, pp. 526-531
Open Access | Times Cited: 2
Analyzing Turning Behavior after Repeated Lithium, Ketamine, or NaCl Injection and Chronic Stress Exposure in Mice
Annakarina Mundorf, Hiroshi Matsui, Sebastian Ocklenburg, et al.
Symmetry (2022) Vol. 14, Iss. 11, pp. 2352-2352
Open Access | Times Cited: 3
Annakarina Mundorf, Hiroshi Matsui, Sebastian Ocklenburg, et al.
Symmetry (2022) Vol. 14, Iss. 11, pp. 2352-2352
Open Access | Times Cited: 3
Innovating translational models of affective disorders
Emma Robinson, Debra A. Bangasser
Psychopharmacology (2023) Vol. 240, Iss. 11, pp. 2217-2220
Open Access | Times Cited: 1
Emma Robinson, Debra A. Bangasser
Psychopharmacology (2023) Vol. 240, Iss. 11, pp. 2217-2220
Open Access | Times Cited: 1
